key: cord-0328422-z5zawv8d
authors: Cong, Lijun; Sugden, Scott M.; Leclair, Pascal; Lim, Chinten James; Pham, Tram NQ.; Cohen, Éric A.
title: HIV-1 Vpu promotes phagocytosis of infected CD4+ T cells by macrophages through downregulation of CD47
date: 2021-03-17
journal: bioRxiv
DOI: 10.1101/2021.03.16.435750
sha: f4ea281898f696db713a4ffaf44dce082a828dce
doc_id: 328422
cord_uid: z5zawv8d

Human immunodeficiency virus (HIV) remodels the cell surface of infected cells to facilitate viral dissemination and promote immune evasion. The membrane-associated Vpu accessory protein encoded by HIV-1 plays a key role in this process by altering cell surface levels of multiple host proteins. Using an unbiased quantitative plasma membrane profiling approach, we previously identified CD47 as a putative host target downregulated by Vpu. CD47 is a ubiquitously-expressed cell surface protein that interacts with the myeloid cell inhibitory receptor SIRPα to deliver a “don’t-eat-me” signal, thus protecting cells from phagocytosis. In this study, we investigate whether CD47 modulation by HIV-1 Vpu might promote the susceptibility of macrophages to viral infection via phagocytosis of infected CD4+ T cells. Indeed, we find that Vpu downregulates CD47 expression on infected CD4+ T cells leading to an enhanced capture and phagocytosis by macrophages. Interestingly, it is through this process that a CCR5-tropic transmitted/founder (T/F) virus, which otherwise poorly infects macrophages in its cell-free form, becomes infectious in macrophages. Importantly, we show that HIV-1-infected cells expressing a Vpu-resistant CD47 mutant are less prone to infect macrophages through phagocytosis. Mechanistically, Vpu forms a physical complex with CD47 through its transmembrane domain and targets the latter for lysosomal degradation. These results reveal a novel role of Vpu in modulating macrophage infection, which has important implications for HIV-1 transmission in early stages of infection and the establishment of viral reservoir. IMPORTANCE Macrophages play critical roles in HIV transmission, viral spread early in infection, and as a reservoir of virus. Selective capture and engulfment of HIV-1 infected T cells was shown to drive efficient macrophage infection suggesting that this mechanism represents an important mode of infection notably for weakly macrophage-tropic T/F viruses. In this study, we provide insight into the signals that regulate this process. We show that the HIV-1 accessory protein Vpu downregulates cell surface levels of CD47, a host protein that interacts with the inhibitory receptor SIRPα to deliver a “don’t-eat-me” signal to macrophages. This allows for enhanced capture and phagocytosis of infected T cells by macrophages, ultimately leading to their productive infection even with T/F virus. These findings provide new insights into the mechanisms governing the intercellular transmission of HIV-1 to macrophages with implications for the establishment of the macrophage reservoir and early HIV-1 dissemination in vivo.

The viral protein U (Vpu) is a membrane-associated accessory protein encoded by 73 human immunodeficiency virus type 1 (HIV-1) and related simian immunodeficiency viruses 74 (SIVs) but not by HIV-2. Consistent with the roles of HIV-1 accessory proteins in targeting 75 cellular restriction factors to favor immune evasion and viral dissemination, Vpu counteracts 76 many host proteins including BST2/Tetherin to promote efficient viral particle release (1, 2) 77 and CD4 to avoid superinfection and subsequent premature cell death (3) . The 78 downregulation of both CD4 and BST2 also protects HIV-1 infected CD4 + T cells from 79 antibody-mediated cellular cytotoxicity (ADCC) (4). Given the contribution of Vpu towards HIV 80 pathogenesis, partly through targeting BST2 and CD4, there is a continuing interest in 81 identifying additional Vpu targets. To date, a diverse list of host factors has been identified 82 including CD1d, NTB-A/SLAM6, PVR/CD155, CCR7, CD62L; SNAT1 (5), ICAM1/3 (6), CD99 83 and PLP2 (7), PSGL-1 (8), Tim-3 (9), and there likely are more to be discovered. Indeed, 84

using a stable isotope labelling of amino acids in cell culture (SILAC)-based proteomic 85 approach, we and others previously identified CD47 as a potential target that is 86

T/F viruses were reported to display a much weaker tropism for MDMs compared to truly containing supernatants from T cell cultures prior to extensive washes to eliminate input 207 target T cells or virions. The former was referred to as "co-culture" while the latter, was 208 designated "cell-free" in Fig. 3 . Conditioned supernatant from both "co-culture" and "cell-free" 209 infections was collected at various time points and quantified for infectious particles using a 210 TZM-bl cell-based luciferase reporter assay (Fig. 3A) . While the media from cell-free-infected 211

MDMs revealed a modest luciferase activity for both ADA and WITO infections, that from 212

MDMs cocultured with infected CD4 + T cells showed meaningfully higher levels (Fig. 3B) . 213

Interestingly, we observed an approximately 6-to 9-fold higher viral production (day 2) for 214

MDMs cocultured with WITO-infected CD4 + T cells compared to those with ADA-infected cells, through cell-to-cell contact with infected CD4 + T cells. To directly support the notion that 218 capture and engulfment of infected T cells was occurring in these conditions, MDMs 219 cocultured with T cells infected with GFP-marked viruses were processed for immunostaining 220 and analysis by confocal microscopy. As shown in Figure 3C , the presence of GFP + MDMs 221 in close contact with T cells or containing intact GFP + T cells could be observed. Furthermore, 222

MDMs displaying a GFP signal following cell-contact showed the presence of multiple nuclei 223 and harbored Gag p17 immunostaining in internal compartments as well as at the cell 224 periphery, suggesting the intercellular transfer of fully mature virus particles to MDM (Figure 225 3D). Taken together with the capture/ phagocytosis data (Fig. 2) , we assert that the improved 226 infection of MDMs is likely a consequence of their engulfment of infected CD4 + T cells. 227

To provide evidence that the infection of MDMs was indeed due to phagocytosis, we 229

introduced Jasplakinolide (Jasp) to the cocultures (Fig. 4A) . Jasp was reported to promote 230 actin polymerization and stabilize actin filaments, thereby inhibiting cellular processes 231 dependent on actin dynamics including phagocytosis (28, 36). In brief, MDMs were pretreated 232 with Jasp, cocultured with WITO-infected CD4 + T cells, and analyzed by flow cytometry for 233 phagocytosis activity (Fig. 4B ) and the frequency of infected (Fig. 4C ) MDMs. Treatment of 234

MDMs with Jasp effectively inhibited phagocytosis (Fig. 4B ) and blocked the infection (Fig.  235 4C). Consistent with these findings, the level of infectious viral particles, measured via 236 luciferase activity in TZM-bl cells was negligible in the supernatant of MDMs cultures following 237

Jasp treatment (Fig. 4D ). As well, the fact that reverse transcriptase inhibitor zidovudine 238 (AZT) or integrase inhibitor raltegravir (Ral) (Fig. S4A We next sought to understand the mechanism involved in Vpu-mediated CD47 254 antagonism. HEK 293T cells were co-transfected with plasmids expressing CD47 and Vpu 255 and analyzed by Western blotting for CD47 expression. CD47 was downregulated by Vpu in 256 a dose-dependent manner by as much as 70% (Fig. 5A) , bringing the question as to how, 257 mechanistically, Vpu mediates the depletion. Thus, we generated Vpu variants that contain 258 mutations within the main functional domains including the: (1) A15L-W23A in the TMD that 259 is involved in various target interactions (38, 39), (2) S53/57A mutation within the DSGNES 13 diserine motif that is involved in the recruitment of the SCF βTrCP E3 ubiquitin ligase, 261 responsible for ubiquitination and degradation of several Vpu targets (40, 41), and (3) 262 A63xxxA67V (AxxxAV for short) within the ExxxLV trafficking motif, which targets Vpu-263 containing complexes to intracellular compartments away from the plasma membrane (42). 264

To this end, we found that all three Vpu mutants prevented CD47 depletion ( Fig. 5B and 265 C(input)), suggesting the importance of the main functional domains of Vpu in this process. 266

Indeed, the A15L-W23A mutant was unable to bind CD47 (Fig. 5C) , implying that the Vpu 267 TMD mediates the complex formation with CD47. To determine whether Vpu induces CD47 268 protein degradation by either the proteasomal or lysosomal pathway, we treated Vpu-and 269 CD47-expressing HEK 293T transfectants with proteasomal inhibitor MG132 or lysosomal 270

inhibitor Concanamycin A (ConA) and found that ConA, but not MG132 prevented CD47 271 depletion (Fig. 5D ). Collectively, these results indicate that Vpu binds CD47 via its TMD and 272 targets the host protein for lysosomal degradation. Conceivably, this process requires both 273 the SCF βTrCP -recruiting DSGNES diserine motif as well as the ExxxLV trafficking signal, 274 consistent with the lack of CD47 degradation by the S53/57A and AxxxAV mutants. 275 276 Furthermore, given that Vpu is typically involved in TMD-TMD interactions with its target 277 proteins, we generated a chimeric CD47 mutant, composed of the extracellular domain 278 (ECD1, aa 1-141) of human CD47 as well as the five membrane-spanning domains (MSDs) 279 and the cytoplasmic tail (CT) of mouse CD47 (Fig. S5) , which displays ~26% of aa sequence 280 divergence mainly found in the first and second MSDs. In this configuration, CD47 became 281 largely resistant to Vpu-mediated degradation, consistent with the fact that the mouse CD47 282 counterpart was unsensitive to Vpu (Fig. S5) . These results suggest that the MSDs are 283 important determinants of human CD47 susceptibility to Vpu-mediated degradation. the chimeric JC47-cCD47 (Fig. 6B ). Next, we investigated the susceptibility of uninfected 296 (mock) and infected JC47-derived cell lines to phagocytosis by MDMs. First, we found that 297 JC47-hCD47 cells were phagocytosed by MDMs to a similar degree as JC47-cCD47 cells, 298 since both showed ~ 5% CD11b + /pHrodo + cells, suggesting that cCD47 was as effective as 299 hCD47 at inducing a "don't-eat-me" signal ( Fig. 6C and Fig. 2C ). Interestingly, upon infection 300 with WT HIV-1, JC47-hCD47 cells were opsonized more efficiently than infected JC47-cCD47 301 cells (Fig. 6C) . Importantly, this difference in phagocytosis was not linked to apoptosis of target cells (Fig. S6) . Furthermore, and in agreement with the phagocytosis results, we 303 observed a heightened virus production as measured by luciferase activity from MDMs co-304 cultured with WT HIV-infected JC47-hCD47 cells (Fig. 6D ) compared to their chimeric JC47-305 cCD47 counterparts. Collectively, these results further underscore our observation that Vpu-306 mediated CD47 downregulation potentiates phagocytosis of infected T cells by MDMs and, 307 consequently, promotes increased productive infection of MDMs. 308

In this study, we extend our previous SILAC-based observation that CD47 is a putative 311 target of HIV-1 Vpu (6, 10) and reveal that Vpu indeed downregulates CD47 on CD4 + T cells 312 infected with lab-adapted X4-tropic NL 4-3, R5-tropic NL 4-3 ADA as well as T/F WITO virus 313 

in higher productive infection of MDMs. To circumvent this problem, we generated a Jurkat 420 cell line expressing human-mouse chimeric CD47, which is relatively resistant to Vpu 421 modulation ( Fig. S5; Fig. 6A and B). Taking advantage of this system, we confirm that Vpu-422 mediated CD47 downregulation contributes to phagocytosis of HIV-1-infected CD4 + T cells 423 by MDMs, leading to enhanced productive infection of MDMs ( Fig. 6C and D) . inserted into pWPI-IRES-Puro-Ak to create pWPI-hCD47 or pWPI-cCD47 for expression of 488 human or chimeric CD47, respectively. All constructs were confirmed by sequencing. In order to rescue CD47 expression in CD47 KO cells, the JC47 cell line was used. Peripheral blood mononuclear cells (PBMCs) were purified from buffy coats following Ficoll 520 density gradient (GE Healthcare). CD4 + T cells were isolated by negative selection using 521

CD4 + T cells were activated with 5 µg/mL phytohemagglutinin-L (PHA-L; Sigma-Aldrich, 523 #11249738001) and 100 U/mL IL-2 (PeproTech, #200-02) for 3 days and cultured in RPMI-524 10 containing 100 U/mL IL-2 for another 2 days before infection. 525

PBMCs were seeded for 2 h at 37°C in non-tissue culture treated dishes (Fisherbrand) 526 containing serum-free RPMI medium. After gentle washes, adherent cells (which mostly 527 contain monocytes) were cultured for 7 days in RPMI supplemented with 5% 528 decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, 529 #216-MC) to obtain MDMs. Purity of MDMs was determined by CD11b surface staining and 530 was found to routinely reach > 95 %.

Virus stocks were obtained by transfecting of HEK 293T cells with proviral DNA in the 535 presence or absence of pSVCMV-VSV-G using polyethylenimine (PEI; Polyscience, #23966). 

For infection of T cell lines, cells were infected at multiplicity of infection (MOI) of 0.5 or 1. 543

Primary CD4 + T cells were infected at MOI of 1 by spin-inoculation as previously described 544 (81). MDMs (seeded at 1 x 10 5 cells/well in 12 well-plate) were infected at MOI of 2 (for NL 545 4-3 ADA) or MOI of 5 (for WITO) in 300 µL of RPMI-10. Viruses were adsorbed for 6 h at 546 37°C before medium was replaced with 1 mL of RPMI-10. 

CD4 + T cells were infected and after 2 days, washed, and maintained in culture for virus 564 release during a 6 h incubation. Supernatants were separated from T cells by centrifugation 565

(300 x g, 5 min), and fraction was added to MDMs for "cell-free" and "co-culture" infections, 

For SDS-PAGE and Western blotting analysis, cells were lysed in RIPA-DOC buffer (10 mM 619 Tris pH7.2, 140 mM NaCl, 8 mM Na2HPO4, 2 mM NaH2PO4, 1% Nonidet-P40, 0.5 % sodium 620 dodecyl sulfate, 1.2 mM deoxycholate) supplemented with protease inhibitors (cOmplete, 621

Roche). Lysates were then mixed with equal volume of 2 x sample buffer (62.5 mM Tris-HCl, 622 pH 6.8, 2 % SDS, 25 % glycerol, 0.01 % bromophenol blue, 5 % β-mercaptoethanol), and 623 incubated at 37°C for 30 min as boiling was reported to cause aggregation of CD47 (82). 624

Proteins from lysates were resolved on 15 % SDS-PAGE, transferred to nitrocellulose 625 membranes, and reacted with primary antibodies. Endogenous CD47 was detected using a 626

sheep polyclonal Ab, HA-tagged exogenous CD47 were detected using a rabbit mAb (clone 627 C29F4). Membranes were then incubated with HRP-conjugated secondary Abs and proteins 628 . The percent MFI values were calculated relative to that obtained in the respective bystander cells. Statistical analysis was performed using Mann-Whitney U-test ( ** , P < 0.01; * , P < 0.05), error bars represent standard deviations (SD). Flow cytometry data for this figure was generated on a CyAn ADP cytometer (Beckman coulter).

Contribution of Vpu, Env, and Nef 680 to CD4 down-modulation and resistance of human immunodeficiency virus type 1-681 infected T cells to superinfection

HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation 684 of CD4 and BST2

Remodeling of the Host Cell

Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and 687

Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells

Large-Scale Arrayed Analysis of

Protein Degradation Reveals Cellular Targets for HIV-1 Vpu

Downregulates Tim-3 from the Surface of Infected CD4(+) T Cells

Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid 704 Metabolism by Vpu and Nef

Barclay AN, Van den Berg TK. 2014. The interaction between signal regulatory protein 710 alpha (SIRPalpha) and CD47: structure, function, and therapeutic target

A functional 715 subset of CD8(+) T cells during chronic exhaustion is defined by SIRPalpha 716 expression

The Phagocytic Function of Macrophage

Enforcing Innate Immunity and Tissue Homeostasis

Macrophages in vaginal but 721 not intestinal mucosa are monocyte-like and permissive to human immunodeficiency 722 virus type 1 infection

Macrophages and HIV-1: An Unhealthy

Apoptotic killing of

HIV-1-infected macrophages is subverted by the viral envelope glycoprotein

Resistance of HIV-infected macrophages to CD8(+) T lymphocyte-730 mediated killing drives activation of the immune system

A comparison of methods for measuring 733 rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART

A minor population of macrophage-tropic HIV-1 746 variants is identified in recrudescing viremia following analytic treatment interruption

Early HIV-1 target cells in human vaginal and 749 ectocervical mucosa

Phenotypic Correlates of

HIV-1 Macrophage Tropism

Macrophages and their 755 relevance in Human Immunodeficiency Virus Type I infection

Generation of transmitted/founder HIV-1 infectious molecular clones and 759 characterization of their replication capacity in CD4 T lymphocytes and monocyte-760 derived macrophages

Macrophage 763 infection via selective capture of HIV-1-infected CD4+ T cells

Tissue myeloid cells in SIV-infected primates acquire viral DNA through 771 phagocytosis of infected T cells

Elevations 773 in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection

Genetic identity, biological phenotype, and 856 evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

Interferon gene expression following HIV 860 type 1 infection of monocyte-derived macrophages

IFITM proteins 864 are incorporated onto HIV-1 virion particles and negatively imprint their infectivity

Resistance of Transmitted Founder HIV-1 to IFITM

Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity

MARCH8 inhibits HIV-1 infection by reducing virion incorporation 878 of envelope glycoproteins

Phagocytosis of Apoptotic Cells in 880 Resolution of Inflammation

Lack of acidification in

Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase

Improved vectors and genome-wide libraries 931 for CRISPR screening

HHV-7): current status

Effects of CCR5 and 935 CD4 cell surface concentrations on infections by macrophagetropic isolates of human 936 immunodeficiency virus type 1

Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by 940 Targeting the CD4 Viral Receptor

HIV-1 Vpr up-regulates 942 expression of ligands for the activating NKG2D receptor and promotes NK cell-943 mediated killing

Chemiluminescent enhanced CD47 detection 51 and analyzed by Western blotting

Representative 1040 flow cytometry dot-plot graphs with the MFI values in infected (GFP-positive) and bystander 1041 cells (GFP-negative), (left); summary graphs of relative surface CD47 expression levels at 1042 48 h after infection (n=4), (right), the percent MFI values were calculated relative to respective 1043 their GFP-negative cells. Statistical analysis was performed using Mann-Whitney U-test ( * , P 1044 < 0.05); error bars represent SD. (C) The indicated mock or HIV-1-infected target cells were 1045 labelled with pHrodo and cocultured with MDMs for 2 h, prior to analysis of MDMs by flow 1046 cytometry. Representative flow cytometry dot-plots of MDMs (CD11b + ) with percentage of 1047 pHrodo + populations corresponding to phagocytosis of target cells by MDMs (left); summary 1048 graphs for MDMs (right) from 6 distinct donors, analyzed by Wilcoxon matched-pairs signed 1049 rank test ( * , P < 0.05; ns, nonsignificant, P > 0.05). (D) JC47-hCD47 or JC47-cCD47 cells 1050 were infected as described and cocultured with MDMs for 6 h. Following washing-off of infected T cells, MDMs were cultured for 2 days

Vpu downregulates overall levels of surface CD47. Jurkat E6.1 cells were 1057 infected with VSV-G pseudotyped GFP-expressing NL 4-3 ADA (WT or dU) viruses and 1058 stained after 48 h with the indicated anti-CD47 mAbs (CC2C6 or B6H12) prior to flow 1059 cytometry analysis. (Left) Representative flow cytometry dot-plot graphs with indication of 1060 MFI values for infected (GFP-positive) and bystander cells (GFP-negative). (Right) Summary 1061 graphs of relative surface

The percent MFI values were calculated relative to the respective GFP-negative cells

Statistical analysis was performed using Mann-Whitney U-test ( * , P < 0.05), error bars 1064 represent SD

Flow cytometry histogram to validate CD47 surface 1068 expression levels in the indicated Jurkat cell lines; the y axis shows relative cell count for 1069 each population (normalized to mode) while the x axis shows fluorescence intensity of CD47. MDMs as determined by CFSE-or pHrodo-labelling, respectively. Knockout of CD47 resulted 1073 in a better capture and phagocytosis of target cells by MDMs; n= 4 donors. (E) Representative 1074 flow cytometry dot-plots of Annexin V-propidium iodide (PI) staining of the indicated tested 1075 mock-infected or HIV

1076 summary graphs for percentage of Annexin V + population of tested target cells (right)

Statistical analysis was

ns, nonsignificant, P > 0.05), error bars represent SD

Experimental controls. (A) Infection of MDMs by WT NL 4-3 ADA (M-tropic) at

) at a MOI of 5; shown are the frequency of Gag + MDMs from 3 donors 1082 at the indicated time points. (B) Infection levels of primary CD4 + T cells used for coculture 1083 with autologous MDMs; intracellular Gag staining was performed at 48 hpi and measured by 1084 flow cytometry

JC47-hCD47 and JC47-cCD47 cells were mock-infected or infected with VSV-G pseudotyped GFP-expressing WT NL 4-3 ADA virus for 48 h, then stained with anti-CD47mAb (clone CC2C6) and analysed by flow cytometry. Representative flow cytometry dot-plot graphs with the MFI values in infected (GFP-positive) and bystander cells (GFP-negative), (left); summary graphs of relative surface CD47 expression levels at 48 h after infection (n=4), (right), the percent MFI values were calculated relative to respective their GFPnegative cells. Statistical analysis was performed using Mann-Whitney U-test ( * , P < 0.05); error bars represent SD. (C) The indicated mock or HIV-1-infected target cells were labelled with pHrodo and cocultured with MDMs for 2 h, prior to analysis of MDMs by flow cytometry. Representative flow cytometry dot-plots of MDMs (CD11b + ) with percentage of pHrodo + populations corresponding to phagocytosis of target cells by MDMs (left); summary graphs for MDMs (right) from 6 distinct donors, analyzed by Wilcoxon matchedpairs signed rank test ( * , P < 0.05; ns, nonsignificant, P > 0.05). (D) JC47-hCD47 or JC47-cCD47 cells were infected as described and cocultured with MDMs for 6 h. Following washing-off of infected T cells, MDMs were cultured for 2 days, media of MDMs was collected to infect TZM-bl, for luciferase assay. Shown are RLU detected with media collected from MDMs of 3 distinct donors, error bars represent SD.